ATAD5 and cancer: Moreover, given that Atad5 heterozygous mice are cancer-prone and that ATAD5 mutations have been detected in tumors of the breast, ovary (26) and endometrium (27), we wondered whether ATAD5 deficiency could be exploited therapeutically.